Birgitta Versluijs

122 References References 1. Cooke KR. Acute lung injury after allo- geneic stem cell transplantation: from the clinic, to the bench and back again. Pediatr Transplant 2005;9:24-36. 2. Shono Y, Docampo MD, Peled JU, Pero- belli SM, Jenq RR. Intestinal microbio- ta-related effects on graft-versus-host disease. Int J Hematol 2015;101:428-37. 3. van Montfrans J, Schulz L, Versluys B, de Wildt A, Wolfs T, Bierings M, et al. Viral PCR positivity in stool before al- logeneic hematopoietic cell transplan- tation is strongly associated with acute intestinal graft-versus-host disease. Biol Blood Marrow Transplant 2015;21:772-4. 4. Huang YJ, Charlson ES, Collman RG, Colombini-Hatch S, Martinez FD, Seni- or RM. The role of the lung microbiome in health and disease. A National Heart, Lung, and Blood Institute workshop re- port. Am J Respir Crit Care Med 2013; 187:1382-7. 5. Kumar D, Erdman D, Keshavjee S, Peret T, Tellier R, Hadjiliadis D, et al. Clinical impact of community-acquired respira- tory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 2005;5:2031-6. 6. Versluys AB, Rossen JW, van Ewijk B, Schuurman R, Bierings MB, Boelens JJ. Strong association between respiratory viral infection early after hematopoie- tic stem cell transplantation and the development of life-threatening acute and chronic alloimmune lung syndro- mes. Biol Blood Marrow Transplant 2010;16:782-91. 7. Versluys AB, van der Ent K, Boelens JJ, Wolfs T, de Jong P, Bierings MB. High diagnostic yield of dedicated pulmonary screening before hematopoietic cell transplantation in children. Biol Blood Marrow Transplant 2015;21:1622-6. 8. van de Pol AC, Wolfs TF, Jansen NJ, van Loon AM, Rossen JW. Diagnostic value of real-time polymerase chain reaction to detect viruses in young children ad- mitted to the paediatric intensive care unit with lower respiratory tract infec- tion. Crit Care 2006;10:R61. 9. Panoskaltsis-Mortari A, Griese M, Mad- tes DK, Belperio JA, Haddad IY, Folz RJ, et al. An official American Thoracic So- ciety research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneu- monia syndrome. Am J Respir Crit Care Med 2011;183:1262-79. 10. Jagasia MH, Greinix HT, Arora M, Wil- liams KM, Wolff D, Cowen EW, et al. National Institutes of Health consensus development project on criteria for cli- nical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Sta- ging Working Group report. Biol Blood Marrow Transplant 2015;21:389-401.e1. 11. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clini- cal manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974;18:295-304. 12. Yanik GA, Grupp SA, Pulsipher MA, Levine JE, Schultz KR, Wall DA, et al. TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consor- tium and Children’s Oncology Group Study (ASCT0521). Biol Blood Marrow Transplant 2015;21:67-73. 13. Yanik GA, Horowitz MM, Weisdorf DJ, Logan BR, Ho VT, Soiffer RJ, et al. Randomized, double-blind, placebo- controlled trial of soluble tumor necro- sis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneu- 7